SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 952.16 |
| Enterprise Value ($M) | 860.94 |
| Book Value ($M) | 110.52 |
| Book Value / Share | 1.31 |
| Price / Book | 8.62 |
| NCAV ($M) | 71.84 |
| NCAV / Share | 0.85 |
| Price / NCAV | 13.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -1.07 |
| Return on Equity (ROE) | -2.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.33 |
| Current Ratio | 6.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 214.21 |
| Assets | 252.89 |
| Liabilities | 142.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Manning Paul B | 7.90 | 5.54 | |
| 13G | BlackRock, Inc. | 5.00 | 0.00 | |
| 13D/A | Caligan Partners LP | 9.80 | 16.06 | |
| 13G | Legend Aggregator, LP | 9.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 105,529 | 780,513 | 13.52 | |
| 94,767 | 1,047,715 | 9.05 | |
| 126,222 | 925,219 | 13.64 | |
| 60,053 | 495,141 | 12.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LIXT – Lixte Biotechnology Holdings, Inc. | LPCN – Lipocine Inc. |
| LPTX – Leap Therapeutics, Inc. | LSTA – Lisata Therapeutics, Inc. |
| LTRN – Lantern Pharma Inc. |
Financial data and stock pages provided by
Fintel.io